AlphaGrep UK Ltd’s Linde LIN Stock Holding History

AlphaGrep UK Ltd’s Portfolio LIN Stock Details LIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$278K	Buy	561 +7	+1%	+$3.3K	0.08%	550
2025 Q4	$236K	Buy	+554	New	+$237K	0.08%	558

Other funds holding LIN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AlphaGrep UK Ltd's LIN Position: Q1 2026 in Review

AlphaGrep UK Ltd increased its Linde (LIN) stake by 1.3% in Q1 2026, buying an estimated $3.3K and bringing the position to 561 shares worth $278K. The position accounts for 0.08% of the portfolio, ranked #550.

AlphaGrep UK Ltd first reported a position in LIN in Q4 2025 and has held it in 2 quarters since. 2,279 funds tracked by Wall St. Rank hold LIN as of Q1 2026.

AlphaGrep UK Ltd held 561 shares of Linde worth $278K as of Q1 2026.
AlphaGrep UK Ltd bought 7 Linde shares in Q1 2026, an estimated $3.3K.
Linde made up 0.08% of AlphaGrep UK Ltd's portfolio in Q1 2026, its #550 holding.
AlphaGrep UK Ltd first reported a position in Linde in Q4 2025 and has held it in 2 quarters since.
2,279 funds tracked by Wall St. Rank held Linde as of Q1 2026.

Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.